Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,830 | -26,370 | -11,840 | -49,070 | -37,850 |
| Depreciation Amortization | 5,920 | 4,170 | 1,820 | 6,670 | 4,920 |
| Other Working Capital | -1,290 | -840 | -2,940 | -1,510 | -5,750 |
| Other Operating Activity | -1,370 | 2,520 | 1,210 | 5,470 | 4,640 |
| Operating Cash Flow | $-30,570 | $-20,520 | $-11,750 | $-38,440 | $-34,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,790 | -1,220 | -740 | -2,030 | -1,540 |
| Net Acquisitions | -2,030 | -2,000 | -2,000 | -6,970 | -6,460 |
| Other Investing Activity | 2,940 | 10,930 | 4,550 | 8,840 | 20,170 |
| Investing Cash Flow | $-880 | $7,710 | $1,810 | $-160 | $12,170 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 27,380 | 8,560 | 7,540 | 44,510 | 42,870 |
| Financing Cash Flow | $27,380 | $8,560 | $7,540 | $44,510 | $42,870 |
| Exchange Rate Effect | 1,050 | 260 | -40 | -840 | -440 |
| Beginning Cash Position | 11,260 | 11,260 | 11,260 | 6,190 | 6,190 |
| End Cash Position | 8,230 | 7,280 | 8,810 | 11,260 | 26,760 |
| Net Cash Flow | $-3,020 | $-3,970 | $-2,450 | $5,060 | $20,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,570 | -20,520 | -11,750 | -38,440 | -34,040 |
| Free Cash Flow | -30,570 | -20,520 | -11,750 | -38,440 | -34,040 |